Back to AZN Stock Lookup

AZN –

Apr 1, 2014 11:49 AM Form 6-K ASTRAZENECA PLC For: Apr 01
Apr 1, 2014 06:20 AM Form 6-K ASTRAZENECA PLC For: Apr 01
Mar 31, 2014 03:11 PM Endocyte (ECYT) Could Field Takeover Approaches as Vintafolide Moves Toward Approval
Mar 31, 2014 09:52 AM Form 6-K ASTRAZENECA PLC For: Mar 31
Mar 31, 2014 09:12 AM Form 6-K ASTRAZENECA PLC For: Mar 31
Mar 31, 2014 08:58 AM Form 6-K ASTRAZENECA PLC For: Mar 31
Mar 26, 2014 11:10 AM Form 6-K ASTRAZENECA PLC For: Mar 26
Mar 21, 2014 07:41 AM Form 6-K ASTRAZENECA PLC For: Mar 20
Mar 20, 2014 04:53 PM Form 6-K ASTRAZENECA PLC For: Mar 20
Mar 20, 2014 07:13 AM Form 6-K ASTRAZENECA PLC For: Mar 20
Mar 20, 2014 06:22 AM Form 6-K ASTRAZENECA PLC For: Mar 20
Mar 19, 2014 11:31 AM Form 6-K ASTRAZENECA PLC For: Mar 19
Mar 19, 2014 08:00 AM AstraZeneca Launches NEXIUM® (Esomeprazole Magnesium) Direct-to-Patient Program
Mar 17, 2014 08:12 AM AstraZeneca (AZN) Completes Enrollment in BRILINTA Phase III
Mar 17, 2014 08:00 AM AstraZeneca Announces Progress on Global PARTHENON Clinical Trial Program with BRILINTA (ticagrelor) in High-Risk Cardiovascular Disease Patient Populations in Advance of American College of Cardiolog
Mar 13, 2014 12:47 PM Morgan Stanley Downgrades AstraZeneca (AZN) to Underweight
Mar 12, 2014 07:13 AM Form 6-K ASTRAZENECA PLC For: Mar 12
Mar 4, 2014 09:31 AM Pre-Open Stock Movers 3/4: (OXBT) (VIPS) (INSY) Higher; (RSH) (MDR) (MDRL) Lower (more...)
Mar 4, 2014 06:16 AM Amarin (AMRN) Files Patent Suit Against AstraZeneca (AZN), Subsidiary
Mar 3, 2014 06:00 PM After Hours Stock Movers 3/3: (VIPS) (DANG) (GWRE) Higher; (MDR) (MNDL) (MCP) Lower (more...)
Mar 3, 2014 04:01 PM Dynavax (DVAX) Will Get $5..4M Milestone from AstraZeneca (AZN)
Mar 3, 2014 11:48 AM Form 6-K ASTRAZENECA PLC For: Mar 03
Mar 3, 2014 11:05 AM Notable Analyst Rating Changes 03/03: (NOK) (KATE) (TDS) Upgraded; (ADSK) (AZN) (RIO) Downgraded
Mar 3, 2014 06:54 AM BofA/Merrill Lynch Downgrades AstraZeneca (AZN) to Underperform
Mar 3, 2014 06:12 AM Form 6-K ASTRAZENECA PLC For: Feb 03
Mar 3, 2014 02:05 AM U.S. FDA Approves Bydureon® Pen (exenatide extended-release for injectable suspension) for Once-Weekly Treatment of Adults with Type 2 Diabetes
Feb 25, 2014 02:22 PM Form 6-K ASTRAZENECA PLC For: Feb 25
Feb 25, 2014 02:06 PM AstraZeneca's (AZN) Myalept Receives FDA Approval
Feb 25, 2014 02:05 PM U.S. FDA approves orphan drug MyaleptTM (metreleptin for injection)
Feb 20, 2014 08:30 AM AstraZeneca Patient Assistance Programs Provided More Than Half a Million Patients with Free Medicine in 2013
Feb 14, 2014 02:08 PM AstraZeneca's (AZN) Crestor Receives FDA Orphan Drug Designation
Feb 12, 2014 10:41 AM Form 6-K ASTRAZENECA PLC For: Feb 12
Feb 11, 2014 03:28 PM Form SC 13G/A ASTRAZENECA PLC Filed by: BlackRock Inc.
Feb 11, 2014 12:59 PM Form 6-K ASTRAZENECA PLC For: Feb 11
Feb 10, 2014 01:07 PM Form 6-K ASTRAZENECA PLC For: Feb 10
Feb 7, 2014 11:52 AM Form 6-K ASTRAZENECA PLC For: Feb 07
Feb 6, 2014 09:14 AM AstraZeneca (AZN) Tops Q4 EPS by 1c
Feb 6, 2014 08:22 AM Form 6-K ASTRAZENECA PLC For: Feb 06
Feb 6, 2014 07:06 AM Form 6-K ASTRAZENECA PLC For: Feb 06
Feb 5, 2014 03:18 PM Trading Radar for 02/06: Philip Morris (PM), Kellogg (K), Expedia (EXPE), Activision (ATVI), Open Table (OPEN) Report
Feb 5, 2014 07:36 AM Form 6-K ASTRAZENECA PLC For: Feb 05
Feb 3, 2014 10:36 AM Form 6-K ASTRAZENECA PLC For: Feb 03
Feb 3, 2014 08:30 AM AstraZeneca Completes Acquisition of Diabetes Alliance Assets in the U.S. from Bristol-Myers Squibb
Feb 3, 2014 06:22 AM AstraZeneca (AZN) Completes Acquisition of Bristol-Myers' (BMY) Diabetes Alliance Interests
Feb 3, 2014 06:19 AM Form 6-K ASTRAZENECA PLC For: Feb 03
Jan 27, 2014 08:48 AM Form 6-K ASTRAZENECA PLC For: Jan 27
Jan 22, 2014 06:13 AM Form 6-K ASTRAZENECA PLC For: Jan 21
Jan 17, 2014 06:21 AM Form 6-K ASTRAZENECA PLC For: Jan 17
Jan 16, 2014 04:28 PM FDA Panel Doesn't Approve of Wider Use for J&J (JNJ), Bayer's Xarelto
Jan 15, 2014 08:05 AM Danske Upgrades AstraZeneca (AZN) to Buy

Back to AZN Stock Lookup